Abeona Therapeutics (ABEO)

• Market cap: $282M
• 1 day: -1.89%
• 5 days: -0.57%
• 1 month: 0.19%
• 3 months: 0.97%
• 6 months: -26.86%
• Year to date: -2.07%
• 1 year: -1.14%
• 5 years: -91.4%
• 10 years: -91.33%
• Sector: Healthcare
• Industry: Biotechnology

About: Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Employees: 136